Cadence Health to Buy Out ProCure Cancer Center

Winfield, Ill.-based Cadence Health will buy out the stake of partner ProCure Treatment Centers Inc., a national company specializing in proton therapy, in the organizations’ shared cancer center, according to a Crain’s Chicago Business report.

Advertisement

The $25 million transaction will increase Cadence Health’s stake in the CDH Proton Center in Warrenville, Ill., a collaboration between the two organizations, from 12 percent to 81 percent, according to the report.

Launched as a startup in 2005, ProCure is currently undergoing a financial restructuring, according to the report.

More Articles on Oncology Partnerships:

Maury Regional, Vanderbilt University Medical Centers Partner for Cancer Center
Boca Raton Regional’s Cancer Center Joins Moffitt Oncology Network
Cooper University Health Care, MD Anderson Cancer Center to Announce Partnership

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.